.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Covington
Mallinckrodt
Federal Trade Commission
Cantor Fitzgerald
UBS
Farmers Insurance
Dow
Boehringer Ingelheim
US Department of Justice

Generated: September 19, 2017

DrugPatentWatch Database Preview

Bayer Healthcare Llc Company Profile

« Back to Dashboard

What is the competitive landscape for BAYER HEALTHCARE LLC, and when can generic versions of BAYER HEALTHCARE LLC drugs launch?

BAYER HEALTHCARE LLC has twenty-seven approved drugs.

There are seven US patents protecting BAYER HEALTHCARE LLC drugs.

There are ninety-three patent family members on BAYER HEALTHCARE LLC drugs in thirty-eight countries.

Summary for Applicant: Bayer Healthcare Llc

Patents:7
Tradenames:21
Ingredients:11
NDAs:27
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc
CHLOR-TRIMETON
chlorpheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL018397-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN
loratadine
SYRUP;ORAL020641-002Nov 27, 2002OTCYesYes► Subscribe► SubscribeY ► Subscribe
Bayer Healthcare Llc
CLARITIN HIVES RELIEF
loratadine
TABLET;ORAL019658-003Nov 19, 2003OTCYesYes► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN REDITABS
loratadine
TABLET, ORALLY DISINTEGRATING;ORAL020704-002Nov 27, 2002OTCYesYes► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
OCUCLEAR
oxymetazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC018471-001May 30, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
GYNE-LOTRIMIN
clotrimazole
CREAM;VAGINAL018052-002Nov 30, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
ZEGERID OTC
omeprazole; sodium bicarbonate
FOR SUSPENSION;ORAL022283-001Jun 17, 2013OTCYesYes► Subscribe► SubscribeY ► Subscribe
Bayer Healthcare Llc
SHADE UVAGUARD
avobenzone; octinoxate; oxybenzone
LOTION;TOPICAL020045-001Dec 7, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN-D 24 HOUR
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL020470-002Nov 27, 2002OTCYesYes► Subscribe► Subscribe► Subscribe
Bayer Healthcare Llc
ZEGERID OTC
omeprazole; sodium bicarbonate
CAPSULE;ORAL022281-001Dec 1, 2009OTCYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Bayer Healthcare Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc
CLARITIN-D 24 HOUR
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL020470-002Nov 27, 2002► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN-D 24 HOUR
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL020470-002Nov 27, 2002► Subscribe► Subscribe
Bayer Healthcare Llc
MYCELEX
clotrimazole
CREAM;TOPICAL018183-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Bayer Healthcare Llc
ZEGERID OTC
omeprazole; sodium bicarbonate
CAPSULE;ORAL022281-001Dec 1, 2009► Subscribe► Subscribe
Bayer Healthcare Llc
MYCELEX
clotrimazole
CREAM;TOPICAL018183-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN REDITABS
loratadine
TABLET, ORALLY DISINTEGRATING;ORAL020704-002Nov 27, 2002► Subscribe► Subscribe
Bayer Healthcare Llc
SHADE UVAGUARD
avobenzone; octinoxate; oxybenzone
LOTION;TOPICAL020045-001Dec 7, 1992► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN
loratadine
SYRUP;ORAL020641-002Nov 27, 2002► Subscribe► Subscribe
Bayer Healthcare Llc
MYCELEX
clotrimazole
CREAM;TOPICAL018183-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Bayer Healthcare Llc
CLARITIN-D 24 HOUR
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL020470-002Nov 27, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for BAYER HEALTHCARE LLC drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole and sodium bicarbonate
Capsules20 mg/1100 mg
ZEGERID OTC
4/20/2010

Non-Orange Book Patents for Bayer Healthcare Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
RE45198Omeprazole solution and method for using same► Subscribe
6,939,550 Stabilized antihistamine syrup► Subscribe
6,514,520 Stabilized antihistamine syrup► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Bayer Healthcare Llc Drugs

Country Document Number Estimated Expiration
South Korea20040047771► Subscribe
European Patent Office1927354► Subscribe
Peru05652000► Subscribe
Australia782488► Subscribe
European Patent Office2305259► Subscribe
Malaysia123325► Subscribe
Austria340574► Subscribe
Canada2594185► Subscribe
European Patent Office1082117► Subscribe
Australia2002330863► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Bayer Healthcare Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB08/005United Kingdom► SubscribeSUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022.
C/GB11/013United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
C0004France► SubscribePRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
01C/013Belgium► SubscribePRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115
C/GB01/012United Kingdom► SubscribePRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
C/GB11/015United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Healthtrust
Colorcon
Farmers Insurance
US Army
Cantor Fitzgerald
Fuji
Medtronic
QuintilesIMS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot